Multiple sclerosis and related disordersHumansMultiple SclerosisRelapsing-RemittingImmunologic FactorsImmunosuppressive Agents
Suboptimal dose of approved disease modifying therapies in management of patients with multiple sclerosis: A systematic review.
Sepideh Paybast, Fatemeh Baghalha, Mohammad Ali Sahraian
Published: 202510.1016/j.msard.2025.106762
Abstract
BACKGROUND: Multiple sclerosis (MS) is the most common immune-mediated neurodegenerative disorder of the central nervous system (CNS). Suboptimal dosing of disease-modifying treatment (DMT) has emerged as an issue of interest in recent years. Herein,…
Preview only. Read the full abstract at the source